Cargando…

Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context

INTRODUCTION: Targeting tumor vasculature is an efficient weapon to fight against cancer; however, activation of alternative pathways to rebuild the disrupted vasculature leads to rapid tumor regrowth. Immunotherapy that exploits host immune cells to elicit and sustain potent antitumor response has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czapla, Justyna, Drzyzga, Alina, Matuszczak, Sybilla, Cichoń, Tomasz, Rusin, Marek, Jarosz-Biej, Magdalena, Pilny, Ewelina, Smolarczyk, Ryszard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465696/ https://www.ncbi.nlm.nih.gov/pubmed/37655095 http://dx.doi.org/10.3389/fonc.2023.1249524

Ejemplares similares

Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma
por: Kułach, Natalia, et al.
Publicado: (2021)

Brachytherapy in a Single Dose of 10Gy as an “in situ” Vaccination
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2020)

The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors
por: Drzyzga, Alina, et al.
Publicado: (2021)

The Effect of Radiotherapy on Cell Survival and Inflammatory Cytokine and Chemokine Secretion in a Co-Culture Model of Head and Neck Squamous Cell Carcinoma and Normal Cells
por: Matuszczak, Sybilla, et al.
Publicado: (2023)

Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2015)

The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells
por: Czapla, Justyna, et al.
Publicado: (2019)

M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2018)

Characteristic of c-Kit(+) progenitor cells in explanted human hearts
por: Matuszczak, Sybilla, et al.
Publicado: (2014)

Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
por: Smolarczyk, Ryszard, et al.
Publicado: (2018)

Author Correction: Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
por: Smolarczyk, Ryszard, et al.
Publicado: (2020)

Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2019)

Human Cardiac Mesenchymal Stromal Cells with CD105(+)CD34(-) Phenotype Enhance the Function of Post-Infarction Heart in Mice
por: Czapla, Justyna, et al.
Publicado: (2016)

D-K(6)L(9) Peptide Combination with IL-12 Inhibits the Recurrence of Tumors in Mice
por: Cichoń, Tomasz, et al.
Publicado: (2014)

Monitoring of diffusion properties and transverse relaxation time of mouse ischaemic muscle after administration of human mesenchymal stromal cells derived from adipose tissue
por: Skorupa, Agnieszka, et al.
Publicado: (2019)

Human ADSC xenograft through IL-6 secretion activates M2 macrophages responsible for the repair of damaged muscle tissue
por: Pilny, Ewelina, et al.
Publicado: (2019)

Prognostic Significance of STING Immunoexpression in Relation to HPV16 Infection in Patients with Squamous Cell Carcinomas of Oral Cavity and Oropharynx
por: Biesaga, Beata, et al.
Publicado: (2022)

Antitumor Effects of Recombinant Antivascular Protein ABRaA-VEGF(121) Combined with IL-12 Gene Therapy
por: Ciomber, Agnieszka, et al.
Publicado: (2013)

Transcriptomes of human mesenchymal cells isolated from the right ventricle and epicardial fat differ strikingly both directly after isolation and long‐term culture
por: Stępniewski, Jacek, et al.
Publicado: (2019)

Novel Local “Off-the-Shelf” Immunotherapy for the Treatment of Myeloma Bone Disease
por: Charvátová, Sandra, et al.
Publicado: (2023)

Identification of MSA-2: An oral antitumor non-nucleotide STING agonist
por: Liu, Jianhua, et al.
Publicado: (2021)

Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
por: Lemos, Henrique, et al.
Publicado: (2020)

STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
por: Zhang, Bo-Dou, et al.
Publicado: (2022)

Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2021)

Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
por: Florian, David C., et al.
Publicado: (2023)

STING Agonists as Cancer Therapeutics
por: Amouzegar, Afsaneh, et al.
Publicado: (2021)

STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
por: Jing, Weiqing, et al.
Publicado: (2019)

The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2022)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023)

429 Eribulin Synergizes with STING Agonists by Enhancing Type 1 Interferon Expression and Improves Antitumor Efficacy as Combination Treatment
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2023)

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
por: Zhang, Peng, et al.
Publicado: (2023)

STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
por: Chelvanambi, Manoj, et al.
Publicado: (2021)

Remodeling of Tumor Microenvironment by Nanozyme Combined cGAS–STING Signaling Pathway Agonist for Enhancing Cancer Immunotherapy
por: Dong, Wenpei, et al.
Publicado: (2023)

STING Agonist-Induced Skin Inflammation Is Exacerbated with Prior Systemic Innate Immune Activation
por: Pyclik, Marcelina, et al.
Publicado: (2023)

Trial watch: STING agonists in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020)

Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment
por: Motais, Benjamin, et al.
Publicado: (2021)

Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
por: Ohkuri, Takayuki, et al.
Publicado: (2017)

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
por: Jang, Su Chul, et al.
Publicado: (2021)

STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
por: Guerini, Danilo
Publicado: (2022)

TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies
por: Carideo Cunniff, Elizabeth, et al.
Publicado: (2022)

Stinging insect identification in children with Hymenoptera venom allergy and their parents
por: Kaszuba, Jagoda, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vj6ri6c35bd4idfghcanj2dbim